Vir Biotechnology, Inc.
Clinical trials sponsored by Vir Biotechnology, Inc., explained in plain language.
-
New hope for hepatitis b: experimental drug combo shows promise
Disease control CompletedThis study tested new drug combinations in 33 adults with chronic hepatitis B, a long-term liver infection. The goal was to see if the treatments could lower the virus to undetectable levels and reduce a key marker of infection (HBsAg). The trial is part of a larger effort to fin…
Phase: PHASE1, PHASE2 • Sponsor: Vir Biotechnology, Inc. • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
New hope for hepatitis b: experimental drug shows promise
Disease control CompletedThis study tested an experimental drug called VIR-2218, given alone or with another medicine (peginterferon), in 84 adults with chronic hepatitis B. The goal was to check safety and how well the drug works against the virus. Researchers measured side effects and looked for drops …
Phase: PHASE2 • Sponsor: Vir Biotechnology, Inc. • Aim: Disease control
Last updated May 01, 2026 15:56 UTC